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The effect of streptozotocin-induced diabetes on
cell proliferation in rat aortic intima-media, as well
as on local gene expression of transforming growth
factor-//1 (TGF-//1) was studied. TGF-//1 mRNA
was measured by solution hybridization and TGF-
//1 protein by ELISA. Proliferation was measured
by bromodeoxyuridine incorporation into DNA two
days after balloon injury. All BrdU-labelled cells
observed were smooth muscle cells. After a diabetes
duration of 2 and 4 weeks, labelled cells were
significantly fewer compared with controls. Circu-
lating levels of total TGF-jI were lowered in rats
with 2 weeks diabetes. Although the balloon injury
procedure by itself stimulated the gene expression
of TGF-]/1, no significant difference in TGFq/1
mRNA content between diabetic and control rats
after injury was found. In conclusion: vascular
smooth muscle proliferation in vivo is inhibited by
the diabetic state in this model of insulin deficient
diabetes and this inhibition is not related to an
impaired local expression of TGF-]/1.
Keywords: Angioplasty, de-endothelialization, DNA synth-
esis, streptozotocin, transforming growth factor-ill
INTRODUCTION
In the development of atherosclerosis and in
restenosis after balloon angioplasty, prolifera-
tion of vascular smooth muscle cells plays a
central role. I1"21 Smooth muscle cell growth is
regulated by different growth factors that are
locally produced in the vessel wall or circulate
in the blood. When proliferation of vascular
smooth muscle cells is provoked by balloon
angioplasty, there is an increased expression of
growth factors such as platelet-derived growth
factor (PDGF),I31 basic fibroblast growth factor
(bFGF),41 insulin-like growth factor-I (IGF-I)I5j
and transforming growth factor-ill (TGF-fll)6" 71
in the vessel wall.
It is well known that diabetes is associated
with an increased risk of atherosclerotic dis-
ease.s During the last years there has been a
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growing interest for the role of TGF-fll in this study. The rats were kept under 12h light:
diabetes associated nephropathy, macrovascu- 12 h darkness cycle and had free access to food
lar complications 91 and wound healing.
[1-13] and water. All animal experiments were made
High glucose has been shown to induce the in agreement with the principles of laboratory
expression of TGF-fll in some cell types I91 animal care and were approved by the local
and circulating levels of TGF-fll are reported ethics committee for animal experiments. Dia-
to be elevated in diabetic rats
[14] and in betes was induced by i.v. injection of streptozo-
NIDDM patients. I151 However, in wounds of tocin (65mg/kg body weight) in a tail vein,
diabetic rats with retarded wound healing, while rats injected with 0.9% NaC1 served as
levels of TGF-fl, bFGF and IGF-I are decreas- controls. Blood samples were taken from tail
ed[11"13] and treatment with TGF-fl has been vein and blood glucose was measured using a
shown to improve wound healing in diabetic hexokinase method (Gluco-quant(R)) or ONE
animals.I1-12 TOUCH(R) test strips for quantitative measure-
Bornfeldt et al., studied the effect of experi- ment of glucose in blood.I2l The rats were
mental diabetes on the response of arteries to considered diabetic if random blood glucose
injury and showed that 3H-thymidine incorpora- concentration exceeded 15 mmol/1.
tion into aortic media two days after balloon
injury was inhibited in rats with streptozotocin-
induced diabetes.51 Another study reported an De-endothelialization
inhibited intima media area ratio in the carotid
artery after balloon injury in the same diabetic
model.
[161 In insulin treated diabetic BB (Bio
breeding) Wistar rats, intima was reported to
be thicker, with more smooth muscle cell lay-
ers than the intima of non-diabetic Wistar rats
following balloon injury to the aorta. I171 In pati-
ents with type II diabetes mellitus, a greater
incidence of restenosis after arterial injury
caused by coronary stenting has been report-
edI18 while wound healing in general is im-
paired.2,
19]
The present study was undertaken to inves-
tigate the effect of diabetes on early cell pro-
liferation in the aorta after injury. We
also investigated if the effect of diabetes was
associated with a change in circulating levels
of TGF-fll or changes in local TGF-fll gene
expression.
De-endothelialization was performed, using a
balloon catheter, according to the method of
Capron et a/. [21] In short, the rats were kept
under light ether anaestesia and a deflated
embolectomy catheter (Fogarty, size 2F, Baxter
Medical) was introduced into the aorta through
the left common carotid artery down to the lev-
el of the renal artery. The balloon was inflated
with 40-50tl distilled water, and withdrawn
to the level of the diaphragm. After the passage
of the diaphragm had been felt, additional
20-30 tl distilled water was inflated. This proce-
dure was repeated three times and the carotid
artery was then double ligated. Control rats
were sham operated: the same procedure was
carried out except that no catheter was intro-
duced into the carotid artery.
Measurement of DNA Synthesis
MATERIALS AND METHODS DNA synthesis was measured two days after
injury. The rats were injected intraperitoneally
Animals with 5-bromo-2’-deoxyuridine (BrdU) 0.1 mg/g
body weight. Two hours after injection, the
Male Sprague-Dawley rats (ALAB, Stockholm, animals were killed and the aortic segment
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artey was removed and immersed in ice-cold
saline. Within 30 minutes, cross sections of the
central part of the aortic segment were cut out
and quickly frozen at -70C. With a setting at
4 tm, cryostat sections were cut out and brought
to chrome-gelatinized glass slides. The slides
were fixed in 70% ethanol for I h and were
allowed to dry. DNA was denatured with
1.5 mol/1 NaOH for 90 sec followed by neutra-
lisation in 0.1 mol/1 Na2B407 (pH 8.5) for 10sec
and rinsing twice in a phosphate buffer (PBS).
After incubation with an anti-BrdU monoclonal
antibody and a peroxidase-conjugated second-
ary antibody developed with diaminobenzidine
as a chromogen, cells in the S-phase were easily
visualized. DNA synthesis was expressed as
number of labelled cells in a whole cross sec-
tion of aortic media layer counted under an
ordinary light microscope (Fig. 1). One cross
section from each aorta was counted.
Measurement of mRNA by a Solution
Hybridization Assay
The intima-media was separated from adventi-
tia according to the method of Wolinsky and
Daly.
[22] The intima-media of the aortas were
homogenized in a glass-glass homogenizer for
30 s. Nucleic acids were extracted essentially as
described by Durnam and Palmiter. I231 Sam-
ples were digested with proteinase K and
extracted with phenol and chloroform. Nucleic
acids were precipitated with ethanol. Total
nucleic acids were measured by spectrophoto-
metry. DNA content was measured by fluori-
metry according to the method of Labarca and
Paigen.
[24]
The mRNA level of TGF-fll was determined
by a solution hybridization assay 231 using a
[35S]-UTP labelled RNA probe complementary
to a lkb fragment spanning the major cod-
ing region of the TGF-fll precursor.
[251 The
probe was prepared according to the method
of Melton et al. [261 and was hybridized to
total nucleic acid (TNA) samples at 70C for
20h. Hybridization was performed in 40tl
of 0.6M NaC1, 20mmol/1 Tris/HC1 (pH 7.5),
4mmol/1 EDTA, 0.1% SDS, 0.75 mmol/1 dithio-
threitol (DTT), 25% formamide and 20000cpm
[35S]-UTP labelled probe per incubation. The
samples were exposed to RNases and the
hybrids precipitated with 100tl TCA (6mol/1),
collected on glass microfibre filters and ra-
dioactivity measured in a liquid scintillation
counter (1214 Rackbeta; LKB). The radioactivity
FIGURE 1 Photomicrograph of the media layer of aorta in a control rat, two days after balloon angioplasty to the aorta. No re-
endothelialization of the injured aorta can be seen at this time point. The structure of the artery wall can be discerned and the
nuclei of two smooth muscle cells in S-phase are strongly labelled by BrdU incorporation. (See Color Plate VI).104 G. DAHLFORS et al.
of each sample was then compared with a RESULTS
standard curve constructed from a sample with
known amount of in vitro synthesized TGF-fll Induction of diabetes was monitored by measur-
sense RNA complementary to the probe. A ing body weight and blood glucose. Blood
standard curve was included in each assay and glucose was markedly elevated and body weight
samples were analysed in triplicate. Tubes of streptozotocin injected rats was lower than
including only hybridization buffer and probe in control rats (Tab. I).
served as blanks. Two days after balloon angioplasty the aortic
intima-media was examined with regard to the
presence of BrdU-labelled cells. At this time
Immunoassay for TGF-//1 point no re-endothelialization of the injured
aorta was seen and of the aortic intima-media Serum levels of TGF-fll were measured by a
quantitative immunoassay kit for TGF-fll (R&D only the media layer was present. All cells
reacting with antibodies against BrdU were Systems). Before analysis TGF-fll protein was
activated by acidification of serum samples.
A standard curve made from recombinant
TGF-fll was included in each assay.
Chemicals
smooth muscle cells (Fig. 1). The number of
labelled cells was lower in diabetic rats as
compared with controls (Fig. 2). Proliferating
cells in aortic media remained low in diabetic
rats, while in nondiabetic rats, BrdU-labelled
cells decreased along with the increased age.
Consequently, the difference between control
Streptozotocin was obtained from Sigma Che- and diabetic rats was more pronounced in
mical Co. (St Louis, MO, USA) and ONE TO- rats with a diabetes duration of 2 and 4 weeks
UCH(R) test strips were from Lifescan (Milpitas, than in rats with 8 weeks diabetes.
California, USA). Gluco-quant(R), 5-bromo- Total TGF-fll was measured in serum from rats
2’deoxyuridine, RNases, Proteinase K and her- with a diabetes duration of 2 weeks (Fig. 3).
ring sperm DNA were from Roche Diagnostics Levels of TGF-fll were slightly but significantly
(Mannheim, Germany). Anti-BrdU monoclonal lower in diabetic animals as compared with
antibody and peroxidase-conjugated second- controls. No difference was seen between balloon
ary antibody was purchased from Dakopatts injured rats and sham operated rats in either
AB (H/igersten, Sweden). Immunoassay kit control animals or diabetic animals. Levels of
for human TGF-fll was obtained from R&D active TGF-fll in serum was measured. A tend-
Systems (Abingdon, UK). [35S]-UTP was from ency to lower values of active serum TGF-fll in
Amersham International (Amersham, Bucks, diabetic rats as compared to controls was seen
UK), chemicals for probe synthesis were re-
ceived from Promega (Madison, WI, USA) and TABLE Body weight and blood glucose in normal and
phenol was obtained from Fisher Scientific diabetic rats(n=3-4)
(Fair Lawn, NJ, USA). Diabetes Body weight (g)
duration At STZ At balloon Blood glucose
(weeks) Rat injection injury (mrnol/1)
Statistics 2 Control 200 4- 2 313 4- 8 6.9 4- 0.2
Values are given as means+SEM. Statistical 4
comparisons were made according to analysis
of variance (ANOVA) with Fisher’s protected 8
least significant difference (PLSD).
Diabetes 194 4- 3 187 4- 8 32.4 4-1.1
Control 195 4-1 360 4-10 6.4 4- 0.5
Diabetes 195 4- 2 206 4- 5 32.0 4- 0.6
Control 198 4- 3 476 4- 9 6.2 4- 0.1
Diabetes 196 4- 3 240 4-18 28.4 4- 0.650-
40-
30-
20-
2 3 4 5 6 7 8 g
Time (weeks)
FIGURE 2 Effect of diabetes on proliferation of cells in rat aorta two days after balloon injury. Proliferation was measured by
BrdU incorporation into DNA. Measurements were made at 2, 4 and 8 weeks of diabetes duration. Open circles represent non-
diabetic control rats while filled circles represent diabetic rats. Bars are the mean 4-SEM (n=3-4). The ANOVA Fisher’s PLSD
was used for statistical comparisons: *** p < 0.001.
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FIGURE 3 Serum levels of total TGF-fll in control (open bars) and 2 week diabetic rats (solid bars) two days after balloon
injury. Bars are the mean 4-SEM (n 5). Statistical comparisons were made according to the ANOVA Fisher’s PLSD: ,p < 0.05,
p<0.01.106 G. DAHLFORS et al.
nos.
Control Diabetes
FIGURE 4 Expression of TGF-fll mRNA in control and diabetic rat aorta two days after balloon injury (solid bars) or sham
operation (open bars). Rats with a diabetes duration of 2 weeks were used for the experiment. Bars are the mean 4-SEM (n=3-
5). Statistical comparisons were made according to the ANOVA Fisher’s PLSD: n.s.=not significant, p < 0.05.
but values were below the lowest point in
the standard curve and it was therefore not
possible to get a quantitative measure of active
TGF-fll.
TGF-fll mRNA was measured after a diabetes
duration of 2 weeks, in aorta of control and
diabetic rats (Fig. 4). Basal level of TGF-fll
mRNA did not differ significantly between
control and diabetic rats. In control rats TGF-
fl mRNA was 1.4+0.5amol/tg DNA and in
diabetic rats, 0.92+0.24amol/tg DNA. There
was an increased expression of TGF-fll after
balloon injury. TGF-fll mRNA levels were
increased from 1.4 4- 0.5 to 1.95 4- 0.24 amol/
tg DNA in control rats and from 0.924-0.35
to 2.46 4- 0.4 amol/tg DNA in diabetic rats
after injury. No significant difference in TGF-
fl mRNA between injured diabetic aortas
(2.46 4- 0.40 amol/tg DNA) and injured control
(1.95 + 0.24amol/tg DNA) aortas was seen.
DISCUSSION
It is known that proliferation of aortic cells
induced by de-endothelialization peaks two
days after injury.
I21] We therefore determined
BrdU-labelling two days after balloon catheter
injury, a time point when the aorta was devoid
of intima and there was no re-endothelializa-
tion. All BrdU-labelled cells were smooth muscle
cells and the number of BrdU-labelled cells
were lowered in diabetic aorta in comparison
to aorta from nondiabetic control rats. Bornfeldt
and coworkers
[51 showed that 3H-thymidine
incorporation into DNA was inhibited in aortaDIABETES AND SMOOTH MUSCLE PROLIFERATION 107
of diabetic rats after balloon injury and that the responded with lower proliferation than
DNA content was lower in diabetic aorta 2 expected.
weeks after injury. In this study and in the It might be argued that streptozotocin by it-
study of Bornfeldt et al., untreated streptozo- self causes the impaired proliferation of smooth
tocin diabetic Sprague-Dawley rats, an insulin muscle cells in diabetic rat aorta. However,
deficient model of diabetes, was used. Another earlier studies in our laboratory showed that
study using the same rat model reported an effects of streptozotocin induced diabetes on
inhibited neointima formation in the carotid Hg-thymidine incorporation5 and C14-1eucine
artery after balloon injury. I161 Our results incorporation
[29] in rat aorta, could be reversed
show that inhibition of smooth muscle cell by insulin treatment. This suggests that the
proliferation is a feature of the inhibited arter- impaired metabolism and growth seen in
ial response to injury in aorta of streptozotocin streptozotocin diabetic rat aortas, is caused by
diabetic rats. In line with these results it was the diabetic state and not by a toxic effect of
recently reported that the hypercellularity of streptozotocin.
the intima is reduced in restenotic tissue from TGF-fll is an important regulator of vascular
diabetic patients while collagen-rich sclerotic smooth muscle cell growth and is reported to
content is increased.27 It was suggested that stimulate smooth muscle cell proliferation after
an accelerated fibrotic rather than a prolife- arterial balloon injury.6" 7] It has, however, also
rative response is the main feature of restenosis been stated that TGF-fll might inhibit smooth
in diabetic patients, muscle cell proliferation in vivo.[31 Expression
In order to see whether diabetes duration of TGF-fll is correlated with increased extra-
had an effect on proliferation of smooth muscle cellular matrix production and neointima for+/-
cells, BrdU incorporation was measured at mation.[6"31"321 In wounds, low levels of TGF-fl
2, 4 and 8 weeks after induction of diabetes, are considered to contribute to the impaired
The proliferative response of smooth muscle healing seen in diabetes.I1-131 The role of
cells in the intima-media remained low in TGF-fll in diabetic vascular diseases is, how-
rats with different diabetes duration without ever, still mainly unknown. We investigated the
any significant change with time. Because, in possibility that the low proliferation of smooth
our study, the proliferation of smooth muscle muscle cells in diabetic rats two days after in-
cells in normal rats decreased along with in- jury might be associated with altered levels of
creased age, the difference between controls circulating TGF-fll and/or a changed expression
and diabetic rats was most pronounced 2 and 4 of TGF-fll as compared with injured controls
weeks after induction of diabetes. It has been locally in the vessel wall. Levels of total cir-
reported that proliferation of vascular smooth culating TGF-fll was slightly but significantly
muscle cells is enhanced by increased age. I281 lower in balloon injured diabetic rats as com-
This does not explain the observed decline pared to balloon injured control rats. The same
in smooth muscle cell proliferation in normal pattern was found in sham operated rats. Active
rats in this study. The proliferative response TGF-fll in serum was measured but levels were
of smooth muscle cells has been shown to below the lowest concentration in the standard
be dependent on the severity of the arterial curve. However, a tendency to lower levels of
injury.71 It is possible that the control rats active TGF-fll was seen in diabetic rats as
at 8 weeks diabetes duration, which were compared to controls in agreement with results
considerably bigger than the control rats at on total TGF-fll. In contrast to these results
4 weeks of diabetes duration, were less injured Bollinenni and colleagues found elevated levels
by the balloon angioplasty procedure and thus of circulating active TGF-fll in diabetic rats 6108 G. DAHLFORS et al.
weeks after induction by streptozotocin and
levels were markedly higher than we found in
this study.
[141 The reason for such a discrepancy
is not evident but might be partly due to the
different methods used for measurement of
TGF-fll, enzyme-linked immunosorbent assay
in our study and a mink-lung epithelial cell
bioassay in the study of Bollinenni and collea-
gues. Also the diabetes duration was different,
2 weeks and 6 weeks respectively.
A previous study,61 reported that TGF-fll
mRNA was elevated after balloon injury to the
aorta of non-diabetic rats. We found a significant
increase in TGF-fll mRNA by balloon injury in
diabetic rats. This increased gene expression of
TGF-fll might contribute to the proliferation of
smooth muscle cells triggered by the balloon
injury procedure.6’71 TGF-fll mRNA in dia-
betic rats after injury was not, however, de-
creased as compared to injured controls. Thus,
the low proliferation of smooth muscle cells in
diabetic rats after injury was not related to a
significant impairment of TGF-fll gene expres-
sion locally. However, other growth factors,
as previously described for IGF-I, Isl might be
of importance for regulating smooth muscle
cell proliferation in diabetic rats after balloon
injury.
In conclusion, balloon injury to rat aorta
induced proliferation of vascular smooth mus-
cle cells. The cell proliferation was impaired in
streptozotocin diabetic rats. Although the injury
procedure by itself increased TGF-fll mRNA
levels, no significant difference in TGF-fll
mRNA levels between injured diabetic rats and
injured controls could be seen, suggesting that
the inhibited smooth muscle cell proliferation
in diabetic rats was not caused by an impaired
local TGF-fll mRNA expression.
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